India  

COVID-19: At Mulund and Ghatkopar, most beneficiaries choose Covaxin

Mid-Day Friday, 2 April 2021 ()
COVID-19: At Mulund and Ghatkopar, most beneficiaries choose CovaxinDay 1 of the vaccination for these citizens received a mixed response with less crowds and those preferring one vaccine over the other
0
shares
ShareTweetSavePostSend
 

You Might Like